logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
S

Søren Rasmussen

University of North Carolina School of Medicine

36H-index
190Paper Count
6.8KCitation Count
Published Papers 51
Publication Date
logo
Effect of semaglutide on kidney outcomes in the SELECT, FLOW, and SOUL trials: a prespecified pooled analysis
errLancet Diabetes & Endocrinology
IF41.8
err2026-08-07
err0
PREAI
errJohannes F E Mann; Sunil V Badve; Florian M M Baeres; Nicolas Belmar; Kirstine Brown-Frandsen; John B Buse; Helen M Colhoun; John E Deanfield; Mads D M Engelmann; G Kees Hovingh; Thomas Idorn; A Michael Lincoff; Ildiko Lingvay; Kenneth W Mahaffey; Darren K McGuire; Richard E Pratley; Søren Rasmussen; Peter Rossing; Naveed Sattar; Katherine R Tuttle
errShare
errSave
Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials
errLANCET
IF88.5
err2024-09-01
err9
PREAI
errKosiborod, Mikhail N.; Deanfield, John; Pratley, Richard; Borlaug, Barry A.; Butler, Javed; Davies, Melanie J.; Emerson, Scott S.; Kahn, Steven E.; Kitzman, Dalane W.; Lingvay, Ildiko; Mahaffey, Kenneth W.; Petrie, Mark C.; Plutzky, Jorge; Rasmussen, Soren; Ronnback, Cecilia; Shah, Sanjiv J.; Verma, Subodh; Weeke, Peter E.; Lincoff, A. Michael
errShare
errSave
Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial
errEUROPEAN HEART JOURNAL
IF35.6
err2024-08-30
err0
errOAAI
errMahaffey, Kenneth W.; Tuttle, Katherine R.; Arici, Mustafa; Baeres, Florian M. M.; Bakris, George; Charytan, David M.; Cherney, David Z., I; Chernin, Gil; Correa-Rotter, Ricardo; Gumprecht, Janusz; Idorn, Thomas; Pugliese, Giuseppe; Rasmussen, Ida Kirstine Bull; Rasmussen, Soren; Rossing, Peter; Sokareva, Ekaterina; Mann, Johannes F. E.; Perkovic, Vlado; Pratley, Richard
errShare
errSave
Effects of Once-Weekly Semaglutide on Kidney Disease Outcomes by KDIGO Risk Category in the SUSTAIN 6 Trial
errKIDNEY INTERNATIONAL REPORTS
IF5.7
err2024-07-01
err3
errOAAI
errTuttle, Katherine R.; Bain, Stephen C.; Bosch-Traberg, Heidrun; Khunti, Kamlesh; Rasmussen, Soren; Sokareva, Ekaterina; Cherney, David Z.
errShare
errSave
Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial
errNATURE MEDICINE
IF50
err2024-06-24
err24
errOAAI
errMann, Johannes F. E.; Rossing, Peter; Bakris, George; Belmar, Nicolas; Bosch-Traberg, Heidrun; Busch, Robert; Charytan, David M.; Hadjadj, Samy; Gillard, Pieter; Gorriz, Jose Luis; Idorn, Thomas; Ji, Linong; Mahaffey, Kenneth W.; Perkovic, Vlado; Rasmussen, Soren; Schmieder, Roland E.; Pratley, Richard E.; Tuttle, Katherine R.
errShare
errSave
Semaglutide and diuretic use in obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF-DM trials
errEUROPEAN HEART JOURNAL
IF35.6
err2024-05-13
err16
errOAAI
errShah, Sanjiv J.; Sharma, Kavita; Borlaug, Barry A.; Butler, Javed; Davies, Melanie; Kitzman, Dalane W.; Petrie, Mark C.; Verma, Subodh; Patel, Shachi; Chinnakondepalli, Khaja M.; Einfeldt, Mette N.; Jensen, Thomas J.; Rasmussen, Soren; Asleh, Rabea; Ben-Gal, Tuvia; Kosiborod, Mikhail N.
errShare
errSave
Semaglutide and cardiovascular outcomes by baseline HbA1c in diabetes: the SUSTAIN 6 and PIONEER 6 trials
errEUROPEAN HEART JOURNAL
IF35.6
err2024-02-28
err3
errOAAI
errMellbin, Linda G.; Bhatt, Deepak L.; David, Jens-Peter; Ekstrom, Kathrine; Petrie, Mark C.; Rasmussen, Soren; Vilsboll, Tina
errShare
errSave
Effects of Semaglutide on Symptoms, Function, and Quality of Life in Patients With Heart Failure With Preserved Ejection Fraction and Obesity: A Prespecified Analysis of the STEP-HFpEF Trial
errCIRCULATION
IF38.6
err2024-01-16
err27
errOAAI
errKosiborod, Mikhail N.; Verma, Subodh; Borlaug, Barry A.; Butler, Javed; Davies, Melanie J.; Jensen, Thomas Jon; Rasmussen, Soren; Marstrand, Peter Erlang; Petrie, Mark C.; Shah, Sanjiv J.; Ito, Hiroshi; Schou, Morten; Melenovsky, Vojtech; Abhayaratna, Walter; Kitzman, Dalane W.
errShare
errSave
Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity
errNEW ENGLAND JOURNAL OF MEDICINE
IF78.5
err2023-09-21
err413
errOAAI
errKosiborod, Mikhail N.; Abildstrom, Steen Z.; Borlaug, Barry A.; Butler, Javed; Rasmussen, Soren; Davies, Melanie; Hovingh, G. Kees; Kitzman, Dalane W.; Lindegaard, Marie L.; Moller, Daniel V.; Shah, Sanjiv J.; Treppendahl, Marianne B.; Verma, Subodh; Abhayaratna, Walter; Ahmed, Fozia Z.; Chopra, Vijay; Ezekowitz, Justin; Fu, Michael; Ito, Hiroshi; Lelonek, Malgorzata; Melenovsky, Vojtech; Merkely, Bela; Nunez, Julio; Perna, Eduardo; Schou, Morten; Senni, Michele; Sharma, Kavita; Van der Meer, Peter; von Lewinski, Dirk; Wolf, Dennis; Petrie, Mark C.
errShare
errSave
Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial
errNATURE MEDICINE
IF50
err2023-08-27
err82
errOAAI
errBorlaug, Barry A.; Kitzman, Dalane W.; Davies, Melanie J.; Rasmussen, Soren; Barros, Eric; Butler, Javed; Einfeldt, Mette Nygaard; Hovingh, G. Kees; Moller, Daniel Vega; Petrie, Mark C.; Shah, Sanjiv J.; Verma, Subodh; Abhayaratna, Walter; Ahmed, Fozia Z.; Chopra, Vijay; Ezekowitz, Justin; Fu, Michael; Ito, Hiroshi; Lelonek, Malgorzata; Melenovsky, Vojtech; Nunez, Julio; Perna, Eduardo; Schou, Morten; Senni, Michele; van der Meer, Peter; Von Lewinski, Dirk; Wolf, Dennis; Kosiborod, Mikhail N.
errShare
errSave
Effect of semaglutide on major adverse cardiovascular events by baseline kidney parameters in participants with type 2 diabetes and at high risk of cardiovascular disease: SUSTAIN 6 and PIONEER 6 post hoc pooled analysis
errCARDIOVASCULAR DIABETOLOGY
IF10.6
err2023-08-24
err4
errOAAI
errRossing, Peter; Bain, Stephen C.; Bosch-Traberg, Heidrun; Sokareva, Ekaterina; Heerspink, Hiddo J. L.; Rasmussen, Soren; Mellbin, Linda G.
errShare
errSave
Neutrophil to lymphocyte ratio predicts cardiovascular events in people with type 2 diabetes: Post hoc analysis of the SUSTAIN 6 and PIONEER 6 cardiovascular outcomes trials
errDIABETES OBESITY & METABOLISM
IF5.7
err2023-05-08
err3
errOAAI
errVerma, Subodh; Husain, Mansoor; Madsen, Christian M.; Leiter, Lawrence A.; Kuhlman, Anja Birk; Vilsboll, Tina; Rasmussen, Soren; Libby, Peter
errShare
errSave
Semaglutide reduces the risk of major adverse cardiovascular events consistently across baseline triglyceride levels in patients with type 2 diabetes: Post hoc analyses of the SUSTAIN 6 and PIONEER 6 trials
errDIABETES OBESITY & METABOLISM
IF5.7
err2023-05-03
err4
errOAAI
errVerma, Subodh; David, Jens-Peter; Leiter, Lawrence A.; Michelsen, Marie Mide; Rasmussen, Soren; Bhatt, Deepak L.
errShare
errSave
Post hoc analysis of SUSTAIN 6 and PIONEER 6 trials suggests that people with type 2 diabetes at high cardiovascular risk treated with semaglutide experience more stable kidney function compared with placebo
errKIDNEY INTERNATIONAL
IF12.6
err2023-04-01
err61
errOAAI
errTuttle, Katherine R.; Bosch-Traberg, Heidrun; Cherney, David Z. I.; Hadjadj, Samy; Lawson, Jack; Mosenzon, Ofri; Rasmussen, Soren; Bain, Stephen C.
errShare
errSave
Effects of once-weekly subcutaneous semaglutide on coronary artery disease outcomes in patients with type 2 diabetes with or at high risk for cardiovascular disease: Insights from the SUSTAIN-6 trial
errDIABETES OBESITY & METABOLISM
IF5.7
err2022-12-23
err1
errOAAI
errKolkailah, Ahmed A.; Lingvay, Ildiko; Dobrecky-Mery, Idit; Aharonovich, Alona; David, Jens-Peter; Holse, Cecilie; Rasmussen, Soren; McGuire, Darren K.
errShare
errSave
Hemoglobin A1c Reduction With the GLP-1 Receptor Agonist Semaglutide Is Independent of Baseline eGFR: post hoc Analysis of the SUSTAIN and PIONEER Programs
errKIDNEY INTERNATIONAL REPORTS
IF5.7
err2022-11-01
err5
errOAAI
errCherney, David Z. I.; Hadjadj, Samy; Lawson, Jack; Mosenzon, Ofri; Tuttle, Katherine; Vrhnjak, Blaz; Rasmussen, Soren; Bain, Stephen C.
errShare
errSave
Impact of semaglutide on high-sensitivity C-reactive protein: exploratory patient-level analyses of SUSTAIN and PIONEER randomized clinical trials
errCARDIOVASCULAR DIABETOLOGY
IF10.6
err2022-09-02
err24
errOAAI
errMosenzon, Ofri; Capehorn, Matthew S.; De Remigis, Alessandra; Rasmussen, Soren; Weimers, Petra; Rosenstock, Julio
errShare
errSave
Effects of Semaglutide on Stroke Subtypes in Type 2 Diabetes: Post Hoc Analysis of the Randomized SUSTAIN 6 and PIONEER 6
errSTROKE
IF8.9
err2022-09-01
err43
errOAAI
errStrain, W. David; Frenkel, Ofir; James, Martin A.; Leiter, Lawrence A.; Rasmussen, Soren; Rothwell, Peter M.; Ripa, Maria Sejersten; Truelsen, Thomas C.; Husain, Mansoor
errShare
errSave
The potential of GLP-1 receptor agonists in type 2 diabetes and chronic kidney disease: from randomised trials to clinical practice
errTHERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM
IF4.6
err2022-07-19
err22
errOAAI
errvon Scholten, Bernt Johan; Kreiner, Frederik Flindt; Rasmussen, Soren; Rossing, Peter; Idorn, Thomas
errShare
errSave
Semaglutide reduces cardiovascular events regardless of metformin use: a post hoc subgroup analysis of SUSTAIN 6 and PIONEER 6
errCARDIOVASCULAR DIABETOLOGY
IF10.6
err2022-04-28
err7
errOAAI
errHusain, Mansoor; Consoli, Agostino; De Remigis, Alessandra; Meyer, Anna Sina Pettersson; Rasmussen, Soren; Bain, Stephen
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
P
Peter Libby
H-index: 227 · Papers: 1.2K
D
Deepak L. Bhatt
H-index: 197 · Papers: 3.7K
K
Kamlesh Khunti
H-index: 162 · Papers: 2.1K
L
Lars Køber
H-index: 155 · Papers: 2.1K
P
Peter M. Rothwell
H-index: 150 · Papers: 1.1K
View more